Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice

Atherosclerosis

Volumn 111, Issue 1, 1994, Pages 25-37

  van Ree, Janine H ^a,b   van den Broek, Walther J A A ^c   Dahlmans, Vivian E H ^b   Groot, Pieter H E ^d   Vidgeon Hart, Martin ^d   Frants, Rune R ^a   Wieringa, Bé ^c   Havekes, Louis M ^b   Hofker, Marten H ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b TNO   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Atherosclerotic plaques; Cholesterol rich diets; Gene targeting; Hyperlipoproteinemia; Mouse model

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL DIET; CONTROLLED STUDY; FEMALE; GENE TARGETING; HETEROZYGOSITY; HISTOLOGY; HYPERLIPOPROTEINEMIA TYPE 3; MALE; MOUSE; PRIORITY JOURNAL;

AGING; ANIMAL; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CHOLESTEROL; CHOLESTEROL, DIETARY; DIET, ATHEROGENIC; DISEASE SUSCEPTIBILITY; FEMALE; GENE TARGETING; HETEROZYGOTE; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; SUPPORT, NON-U.S. GOV'T;

EID: 0028081754     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(94)90188-0     Document Type: Article

References (38)

1. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology
2. Apolipoprotein E: genetic variants provide insights into its structure and function
3. Type III hyperlipoproteinerna associated with apolipoprotein E deficiency
4. A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency
5. Apolipoprotein E deficiency with a depressed mRNA of normal size
6. Familial apolipoprotein E deficiency and type III hyperlipoproteinemia due to a premature stop codon in the apolipoprotein E gene
7. Genetic polymorphism of apolipoprotein E — impact on plasma lipoprotein metabolism
8. Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree
9. Type III hyperlipoproteinerna associated with apolipoprotein E phenotype E3/3. Structure and genetics of an apolipoprotein E3 variant
10. ∗3-Leiden gene exhibit hyperlipoproteinemia
11. Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E
12. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells
13. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
14. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
15. Diet-induced hyperlipoproteinema and atherosclerosis in apolipoprotein E3-Leiden transgenic mice
16. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
17. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression [published erratum appears in Arterioscler Thromb 1994 May;14(5):839]
18. Evolutionary conservation of the mouse apolipoprotein E-C1-C2 gene cluster: struc ture and genetic variability in inbred mice
19. Modulation of gene activity by consecutive gene targeting of one creatine kinase M allele in mouse embryonic stem cells
20. Targeting of the creatine kinase M gene in embryonic stem cells using isogenic and nonisogenic vectors
21. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for target ing mutations to non-selectable genes
22. The Wnt-1 (int1) proto-oncogene is required for development of a large region of the mouse brain
23. Production and analysis of chimeric mice
24. Structure and expression of mouse apolipoprotein E gene
25. Northern blot analysis of gene expression
26. Protein measurement with the folin phenol reagent
27. Quantitative assessment of atherosclerotic lesions in mice
28. Synthetic low and high fat diets for the study of atherosclerosis in the mouse
29. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II
30. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H
31. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice
32. Atherogenesis. Insights from the study of transgenic and gene-targeted mice
33. The mouse model for atherosclerosis
34. Transgenic mouse models of lipoprotein metabolism and atherosclerosis
35. In the absence of a downstream element, the apolipoprotein E gene is expressed at high levels in kidneys of transgenic mice
36. Accumulation of human apolipoprotein E in the plasma of transgenic mice
37. Hepatic and renal expression of rat apolipoprotein E under control of the metallothionein promotor in transgenic mice
38. Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipo protein and resistance against diet-induced hypercholesterolemia